KATHRYN KIRK: Open Payments
NPI 1891269536 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 8 payments from 6 companies in 2025. Trend: 2023 $2,522 · 2024 $176 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| AtriCure, Inc. | 1 | $43 |
| Amgen Inc. | 1 | $27 |
| MEDICOMP INC | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LEQVIO, ATRICLIP LAA EXCLUSION SYSTEM, REPATHA, TELEPATCH CARDIAC MONITOR, ONPATTRO, FARXIGA.
Industry payments across PA — which companies pay providers there.
